Interview, Fireside Chat, Podcast
Battery Ventures’ Chelsea Stoner on the power of being ‘stage agnostic’ in tech investing
- The exit spigot for private companies is expected to stabilize, with the pipeline of private unicorns going public likely taking five to six years.
- Decelerated companies requiring additional capital will eventually secure funding, though the specific timing remains uncertain.
- Market alignment regarding necessary consolidation may require an extended period due to the difficulty in coordinating capital structures with numerous players.
- Healthcare delivery is projected to undergo faster-than-anticipated transformation driven by generative AI, which serves as the trigger for clinical outcomes and cost reductions.
- Despite technological potential, the healthcare industry currently faces widespread frustration regarding existing care models.
- The valuation gap between early-stage and late-stage companies is expected to persist for a prolonged period while capital allocates and companies resume accelerated growth.
- Battery Ventures intends to maintain analyst diversity representation of at least 50-50 among its final classes, reflecting a hiring shift directly from college.
- AI integration is anticipated to significantly benefit the "opera" of healthcare, specifically improving both outcome quality and delivery costs.